Genetic heterogeneity and its effect on susceptibility to environmental factors

European Journal of Oncology

Volumn 12, Issue 3, 2007, Pages 155-170

  Scinicariello, Franco ^a   De Rosa, Christopher T ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

Author keywords

Genetic polymorphism; Risk assessment; Xenobiotic

Indexed keywords

ACYLTRANSFERASE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CARCINOGEN; CYTOCHROME P450; GLUTATHIONE TRANSFERASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); XENOBIOTIC AGENT;

BIOTRANSFORMATION; CATALYSIS; DETOXIFICATION; ENVIRONMENTAL FACTOR; ENZYME MECHANISM; GENE MUTATION; GENETIC DIFFERENCE; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; METABOLISM; MUTAGENESIS; NONHUMAN; REVIEW; RISK ASSESSMENT;

EID: 35848950758     PISSN: 11286598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Ruwende C, Khoo SC, Snow RW, et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995; 376: 246-9.
2. Kelada SN, Eaton DL, Wang SS, et al. The role of genetic polymorphisms in environmental health. Environ Health Perspect 2003; 111: 1055-64.
3. Graur D, Li WH. Fundamental of molecular evolution. 2nd ed. Sunderland: Sinaeur Associates, Inc, 2000, 57.
4. Hallier E, Langhof T, Dannappel D, et al. Polymorphisms of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: influence on the induction of sister chromatid exchanges (SCE) in lymphocytes. Arch Toxicol 1993; 67: 173-8.
5. El-Masri HA, Bell DA, Portier CJ. Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans. Toxicol Appl Pharmacol 1999; 158: 221-30.
6. Garnier R, Rambourg-Schepens MO, Muller A. Glutathione transferase activity and formation of macromolecular adducts in two cases of acute methyl bromide poisoning. Occup Environ Med 1996; 53: 211-5.
7. Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 2006; 6: 947-60.
8. Bartsch H, Nair U, Risch A, et al. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000; 9: 3-28.
9. Masson LF, Sharp L, Cotton SC, et al. Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol 2005; 161: 901-15.
10. Safe S, Bandiera S, Sawyer T, et al. PCBs: structure-function relationships and mechanism of action. Environ Health Perspect 1985; 60: 47-56.
11. Scinicariello F, Moffett DB, Murray HE. PCB, CYP1A1 polymorphism and risk of breast cancer in postmenopausal women. 2007 submitted.
12. Crofts F, Taioli E, Trachman J, et al. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994; 15: 2961-3.
13. Nesaretnam K, Darbre P. 3,5,3′,5′-tetrachlorobiphenyl is a weak oestrogen agonist in vitro and in vivo. J Steroid Biochem Mol Biol 1997; 62: 409-18.
14. Rose RL, Khan MA, Li M-H, et al. Endocrine effects of episodic polychlorinated biphenyl (PCB) congeners. Rev Toxicol Environ Toxicol 2002; 2: 1-18.
15. Buchanan DL, Ohsako S, Tohyama C, et al. Dioxin inhibition of estrogen-induced mouse uterine epithelial mitogenesis involves changes in cyclin and transforming growth factor-beta expression. Toxicol Sci 2002; 66: 62-8.
16. Oenga GN, Spink DC, Carpenter DO. TCDD and PCBs inhibit breast cancer cell proliferation. Toxicol In Vitro 2004; 18: 811-9.
17. Wang F, Samudio I, Safe S. Transcriptional activation of cathepsin D gene expression by 17β-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol Cell Endocrinol 2001; 172: 91-103.
18. Wormke M, Stoner M, Saville B, et al. The aryl hydrocarbon receptor mediates degradation of the estrogen receptor through activation of proteasomes. Mol Cell Biol 2003; 23: 1843-55.
19. Ohtake F, Takeyama K, Matsumoto T, et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 2003; 423: 545-50.
20. Lind PM, Eriksen EF, Sahlin L, et al. Effects of the antiestrogenic environmental pollutant 3,30,4,40, 5-pentachlorobiphenyl (PCB #126) in rat bone and uterus: diverging effects in ovariectomized and intact animals. Toxicol Appl Pharmacol 1999; 154: 236-44.
21. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45: 51-88.
22. Cotton SC, Sharp L, Little J, et al. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 2000; 151: 7-32.
23. Geisler SA, Olshan AF. GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am J Epidemiol 2001; 154: 95-105.
24. Norppa H, Hirvonen A, Jeventaus H, et al. Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes. Carcinogenesis 1995; 16: 1261-4.
25. van Poppet G, de Vogel N, van Balderen PJ, et al. Increased cytogenetic damage in smokers deficient in glutathione S-transferase isoenzyme mu. Carcinogenesis 1992; 13: 303-5.
26. Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): c-DNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300: 271-6.
27. Sorsa M, Osterman-Golkar S, Peltonen K, et al. Assessment of exposure to butadiene in the process industry. Toxicology 1996; 113: 77-83.
28. el-Zein R, Conforti-Froes N, Au WW. Interactions between genetic predisposition and environmental toxicants for development of lung cancer. Environ Mol Mutagen 1997; 30: 196-204.
29. Seow A, Vainio H, Yu MC. Effect of glutathione-S-transferase polymorphisms on the cancer preventive potential of isothiocyanates: an epidemiological perspective. Mutat Res 2005; 592: 58-67.
30. Seidegard J, Vorachek WR, Pero RW, et al. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988; 85: 7293-7.
31. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45: 51-88.
32. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide (1.0). IARC Cancer Base No. 5. Lyon: IARC, 2001.
33. http://seer.cancer.gov/statfacts/html/urinb.html
34. International Agency for Research on Cancer. Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 38. Tobacco smoking. Lyon: IARC, 244-68.
35. Zeegers MP, Tan FE, Verhagen AP, et al. Elevated risk of cancer of the urinary tract for alcohol drinkers: a meta-analysis. Cancer Causes Control 1999; 10: 445-51.
36. Sun CL, Yuan JM, Arakawa K, et al. Dietary soy and increase risk of bladder cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 2002; 11: 1674-7.
37. Bruemmer B, White E, Vaughan TL, et al. Nutrient intake in relation to bladder cancer among middle-aged men and women. Am J Epidemiol 1996; 144: 485-95.
38. Gago-Dominguez M, Castelao JE, Yuan JM, et al. Use of permanent hair dyes and bladder-cancer risk. Int J Cancer 2001; 91: 903-6.
39. Engel LS, Taioli E, Pfeiffer R, et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002; 156: 95-109.
40. Garcia-Closas M, Malats N, Silverman D, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005; 366: 649-59.
41. Agency for Toxic Substances and Disease Registry. Toxicological profile for lead. Atlanta, GA: US Department of Health and Human Services, Public Health Service, 1999: 587.
42. Brennan MJ, Cantrill RC. Delta-aminolaevulinic acid is a potent agonist for GABA autoreceptors. Nature 1979; 280: 514-5.
43. Wetmur JG, Kaya AH, Plewinzka M, et al. Molecular characterization of the human δ-aminolevulinate dehydratase 2 (ALAD 2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet 1991; 49: 757-63.
44. Fleming DE, Chettle DR, Wetmur JG, et al. Effect of the delta-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers. Environ Res 1998; 77: 49-61.
45. Alexander BH, Checkoway H, Costa-Mallen P, et al. Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers. Environ Health Perspect 1998; 106: 213-6.
46. Astrin KH, Bishop DF, Wetmur JG, et al. Delta-aminolevulinic acid dehydratase isozymes and lead toxicity. Ann NY Acad Sci 1987; 514: 23-9.
47. Smith CM, Wang X, Hu H, et al. A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect 1995; 103: 248-53.
48. Wetmur JG, Lehnert G, Desnick RJ. The delta-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res 1991; 56: 109-19.
49. Sousa MG, Silva MC, Duarte AF, et al. Delta-aminolevulinate dehydrase (ALAD) polymorphism in mixed Brazilians from the State of Bahia. Gene Geogr 1991; 5: 33-7.
50. Perez-Bravo F, Ruz M, Moran-Jimenez MJ, et al. Association between aminolevulinate dehydrase genotypes and blood lead levels in children from a lead-contaminated area in Antofagasta, Chile. Arch Environ Contam Toxicol 2004; 47: 276-80.
51. Benkmann HG, Bogdanski P, Goedde HW. Polymorphism of delta-aminolevulinic acid dehydratase in various populations. Hum Hered 1983; 33: 62-4.
52. Sakai T, Morita Y, Araki T, et al. Relationship between delta-aminolevulinic acid dehydratase genotypes and heme precursors in lead workers. Am J Ind Med 2000; 38: 355-60.
53. Schwartz BS, Lee BK, Stewart W, et al. Associations of delta-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol 1995; 142: 738-45.
54. Schwartz BS, Lee BK, Lee GS, et al. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Environ Health Perspect 2000; 108: 949-54.
55. Shen XM, Wu SH, Yan CH, et al. Delta-aminolevulinate dehydratase polymorphism and blood lead levels in Chinese children. Environ Res 2001; 85: 185-90.
56. Hsieh LL, Liou SH, Chen YH, et al. Association between aminolevulinate dehydrogenase genotype and blood lead levels in Taiwan. J Occup Environ Med 2000; 42: 151-5.
57. Wu FY, Chang PW, Wu CC, et al. Lack of association of delta-aminolevulinic acid dehydratase genotype with cytogenetic damage in lead workers. Int Arch Occup Environ Health 2004; 77: 395-400.
58. Chia SE, Zhou HJ, Yap E, et al. Association of renal function and delta-aminolevulinic acid dehydratase polymorphism among Vietnamese and Singapore workers exposed to inorganic lead. Occup Environ Med 2006; 63: 180-6.
59. Bergdahl IA, Gerhardsson L, Schutz A, et al. Delta-aminolevulinic acid dehydratase polymorphism: influence on lead levels and kidney function in humans. Arch Environ Health 1977; 52: 91-6.
60. Ziemsen B, Angerer J, Lehnert G, et al. Polymorphism of delta-aminolevulinic acid dehydratase in lead-exposed workers. Int Arch Occup Environ Health 1986; 58: 245-7.
61. Raczek E. Polymorphism of delta-aminolevulinate dehydratase in the upper Silesian population, Poland. Hum Hered 1994; 44: 172-4.
62. Battistuzzi G, Petrucci R, Silvagni L, et al. δ- aminolevulinate dehydrase: a new genetic polymorphism in man. Ann Hum Genet 1981; 45: 223-9.
63. Petrucci R, Leonardi A, Battistuzzi G. The genetic polymorphism of delta-aminolevulinate dehydrase in Italy. Hum Genet 1982; 60: 289-90.
64. Garcia-Orad A, Aguirre AI, Mazon LI, et al. Polymorphism of delta-aminolevulinic acid dehydratase in Basque populations. Hum Hered 1987; 37: 321-2.
65. Caeiro B, Rey D. Genetic heterogeneity of delta-aminolevulinate dehydrase and phosphoglycolate phosphatase in northwest Spain. Hum Hered 1985; 35: 21-4.
66. Amorim A, Rocha J, Santos MT. Distribution of ACP1, AK1 and ALAD polymorphisms in northern Portugal. Gene Geogr 1994; 8: 147-50.
67. Kapotis C, Tsomi A, Babionitakis A, et al. The genetic polymorphism of aminolevulinate dehydratase (ALADH) in Greece. Hum Hered 1998; 48: 155-7.
68. Suzen HS, Duydu Y, Aydin A. Molecular analysis of delta-aminolevulinic acid dehydratase (ALAD) gene polymorphism in a Turkish population. Biochem Genet 2004; 42: 461-7.
69. Ben-Ezzer J, Oelsner H, Szeinberg A. Genetic polymorphism of delta-aminolevulinate dehydrase in several population groups in Israel. Hum Hered 1987; 37: 229-32.
70. Scinicariello F, Murray HE, Moffett DB, et al. Lead and delta-aminolevulinic acid dehydratase polymorphism: where does it lead? A meta-analysis.Environ Health Perspect 2007; 115: 35-41.
71. Boyle P, Autier P, Bartelink H, et al. European code against cancer and scientific justification: third version. Ann Oncol 2003; 14: 973-1005.
72. Wight AJ, Ogden GR. Possible mechanisms by which alcohol may influence the development of oral cancer - a review. Oral Oncol 1998; 34: 441-7.
73. International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks to humans. Vol. 71. Reevaluation of some organic chemicals, hydrazine and hydrogen peroxide (part two) Acetaldehyde. Lyon: IARC, 1999: 319-35.
74. Clemens DL, Forman A, Jerrells TR, et al. Relationship between acetaldehyde levels and cell survival in ethanol-metabolizing hepatoma cells. Hepatology 2002; 35: 1196-204.
75. Rintala J, Jaatinen P, Parkkila S, et al. Evidence of acetaldehyde-protein adduct formation in rat brain after lifelong consumption of ethanol. Alcohol 2000; 35: 458-63.
76. Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol 2006; 7: 149-56.
77. Osier MV, Pakstis AJ, Soodyall H, et al. A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet 2002; 71: 84-99.
78. Kawamoto T, Koga M, Murata K, et al. Effects of ALDH2, CYP1A1, and CYP2E1 genetic polymorphisms and smoking and drinking habits on toluene metabolism in humans. Toxicol Appl Pharmacol 1995; 133: 295-304.
79. Kielhorn J, Melber C, Wahnschaffe U, et al. Vinyl chloride: still a cause for concern. Environ Health Perspect 2000; 108: 579-88.
80. Goedde HW, Agarwal DP, Fritze G, et al. Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet 1992; 88: 344-6.
81. Higuchi S, Matsushita S, Murayama M, et al. Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. Am J Psychiatry 1995; 152: 1219-21.
82. Higuchi S, Matsushita S, Imazeki H, et al. Aldehyde dehydrogenase genotypes in Japanese alcoholics. Lancet 1994; 343: 741-2.
83. Renwick AG. The use of safety or uncertainty factors in the setting of acute reference doses. Food Addit Contain 2000; 17: 627-35.
84. Sanderson S, Emery J, Higgins J. CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis. Genet Med 2005; 7: 97-104.
85. Enomoto N, Takase S, Yasuhara M, et al. Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcohol Clin Exp Res 1991; 15: 141-4.
86. Mizoi Y, Yamamoto K, Ueno Y, et al. Involvement of genetic polymorphism of alcohol and aldehyde dehydrogenases in individual variation of alcohol metabolism. Alcohol Alcohol 1994; 29: 707-10.
87. Census 2000 Basics. Washington, DC: US Census Bureau, 2002.
88. International Organization of Migration. World Migration Report, 2003.
89. Woodward D, Drager N, Beaglehole R, et al. Globalization and health: a framework for analysis and action. Bull World Health Organ 2001; 79: 875-81.
90. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997; 349: 1498-504.
91. Census 1990 Basics. Washington, DC: US Census Bureau http://www.census. gov/main/www/cen1990.html
92. US Census Bureau. http://quickfacts.census.gov/qfd/